Immortal Ozurdex: A 10-month follow-up of an intralenticular implant

A 78-year-old male who had received a dexamethasone implant (Ozurdex, Allergan, Inc., Irvine, CA, USA) 15 days back for recalcitrant diabetic macular edema in the left eye came to us for a second opinion. On examination, his corrected distance visual acuity was 20/20 in the right eye and 20/40 in th...

Full description

Bibliographic Details
Main Authors: B Poornachandra, Vinod B M Kumar, Chaitra Jayadev, Subashchandra H Dorelli, Naresh Kumar Yadav, Rohit Shetty
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=255;epage=257;aulast=Poornachandra
_version_ 1819042969426067456
author B Poornachandra
Vinod B M Kumar
Chaitra Jayadev
Subashchandra H Dorelli
Naresh Kumar Yadav
Rohit Shetty
author_facet B Poornachandra
Vinod B M Kumar
Chaitra Jayadev
Subashchandra H Dorelli
Naresh Kumar Yadav
Rohit Shetty
author_sort B Poornachandra
collection DOAJ
description A 78-year-old male who had received a dexamethasone implant (Ozurdex, Allergan, Inc., Irvine, CA, USA) 15 days back for recalcitrant diabetic macular edema in the left eye came to us for a second opinion. On examination, his corrected distance visual acuity was 20/20 in the right eye and 20/40 in the left eye. Early cataractous changes were present in both eyes. The intraocular pressure was within normal limits. The Ozurdex implant was seen lodged in the posterior cortex of the crystalline lens in the left eye, confirmed on anterior segment optical coherence tomography (OCT) and ultrasound biomicroscopy. Fundus examination showed moderate nonproliferative diabetic retinopathy in both eyes with macular edema and epiretinal membrane in the left eye, confirmed on OCT. The patient was noncompliant and returned after 10 months. Interestingly, the implant was still present in the same location with the same vision and anterior segment findings as before. The OCT showed a reduction in macular edema. The patient was advised regular follow-up and cataract surgery at a later date.
first_indexed 2024-12-21T09:49:20Z
format Article
id doaj.art-adb43e8e87f64e3f9c2cb12fc5d5455c
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-21T09:49:20Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-adb43e8e87f64e3f9c2cb12fc5d5455c2022-12-21T19:08:14ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892017-01-0165325525710.4103/ijo.IJO_634_16Immortal Ozurdex: A 10-month follow-up of an intralenticular implantB PoornachandraVinod B M KumarChaitra JayadevSubashchandra H DorelliNaresh Kumar YadavRohit ShettyA 78-year-old male who had received a dexamethasone implant (Ozurdex, Allergan, Inc., Irvine, CA, USA) 15 days back for recalcitrant diabetic macular edema in the left eye came to us for a second opinion. On examination, his corrected distance visual acuity was 20/20 in the right eye and 20/40 in the left eye. Early cataractous changes were present in both eyes. The intraocular pressure was within normal limits. The Ozurdex implant was seen lodged in the posterior cortex of the crystalline lens in the left eye, confirmed on anterior segment optical coherence tomography (OCT) and ultrasound biomicroscopy. Fundus examination showed moderate nonproliferative diabetic retinopathy in both eyes with macular edema and epiretinal membrane in the left eye, confirmed on OCT. The patient was noncompliant and returned after 10 months. Interestingly, the implant was still present in the same location with the same vision and anterior segment findings as before. The OCT showed a reduction in macular edema. The patient was advised regular follow-up and cataract surgery at a later date.http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=255;epage=257;aulast=PoornachandraCataractdiabetic macular edemaintralenticular Ozurdex
spellingShingle B Poornachandra
Vinod B M Kumar
Chaitra Jayadev
Subashchandra H Dorelli
Naresh Kumar Yadav
Rohit Shetty
Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
Indian Journal of Ophthalmology
Cataract
diabetic macular edema
intralenticular Ozurdex
title Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
title_full Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
title_fullStr Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
title_full_unstemmed Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
title_short Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
title_sort immortal ozurdex a 10 month follow up of an intralenticular implant
topic Cataract
diabetic macular edema
intralenticular Ozurdex
url http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=255;epage=257;aulast=Poornachandra
work_keys_str_mv AT bpoornachandra immortalozurdexa10monthfollowupofanintralenticularimplant
AT vinodbmkumar immortalozurdexa10monthfollowupofanintralenticularimplant
AT chaitrajayadev immortalozurdexa10monthfollowupofanintralenticularimplant
AT subashchandrahdorelli immortalozurdexa10monthfollowupofanintralenticularimplant
AT nareshkumaryadav immortalozurdexa10monthfollowupofanintralenticularimplant
AT rohitshetty immortalozurdexa10monthfollowupofanintralenticularimplant